Search clinical trials for: Sphingosine 1 Phosphate Receptor Modulators
Total 7543 results
-
Washington University School of MedicineRecruitingAlzheimer DiseaseUnited States
-
ActelionCompletedMultiple SclerosisUnited States, Spain, Hungary, Israel, Portugal, Germany, Russian Federation, Belarus, Poland, Serbia, Latvia, Turkey, Croatia, Canada, Czechia, Bulgaria, Bosnia and Herzegovina, Finland, France, Georgia, Greece, Italy, Lithuania, Mexico and more
-
Novartis PharmaceuticalsTerminatedSecondary Progressive Multiple Sclerosis With Inflammatory Disease ActivitySwitzerland
-
CelgeneCompleted
-
Beth Israel Deaconess Medical CenterNot yet recruitingUlcerative ColitisUnited States
-
Bristol-Myers SquibbRecruitingUlcerative ColitisKorea, Republic of
-
Kessler FoundationCelgene; Hackensack Meridian Health; St. Barnabas Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Novartis PharmaceuticalsAvailable
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentHungary, Russian Federation
-
Bristol-Myers SquibbRecruitingColitis, UlcerativeUnited States, Belgium, Germany, Japan, France, Poland, Russian Federation, Spain, Australia, Canada, Israel, United Kingdom
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisUnited States
-
CelgeneActive, not recruitingCrohn DiseaseUnited States, Italy, Germany, Russian Federation, Argentina, Australia, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, Finland, France, Georgia, India, Ireland, Israel, Korea, Republic... and more
-
CelgeneRecruitingCrohn DiseaseUnited States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Korea, Republic of, Latvia, Mexico, Moldova, Republic of, Poland, Romani... and more
-
CelgeneCompletedCrohn DiseaseUnited States, Spain, Australia, Austria, Bulgaria, Canada, China, Colombia, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, Israel, Korea, Republic of, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Se... and more
-
Tang-Du HospitalNot yet recruitingIntracerebral Hemorrhage
-
Brigham and Women's HospitalBristol-Myers SquibbNot yet recruitingMultiple Sclerosis | Fatigue
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisDenmark, Spain, Switzerland, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Cyprus, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Mexico, Netherlands, Norway, Poland, ... and more
-
Novartis PharmaceuticalsCompleted
-
CelgeneCompletedUlcerative ColitisKorea, Republic of, United States, Belgium, Israel, Netherlands, Australia, Germany, Hungary, New Zealand, Italy, Canada, Bulgaria, Croatia, United Kingdom, Argentina, Austria, Belarus, Czechia, Georgia, Moldova, Republic of, Po... and more
-
Novartis PharmaceuticalsTerminatedPolymyositisHungary, Taiwan, United States, Canada, Czechia, Poland
-
Novartis PharmaceuticalsCompleted
-
The University of Texas at DallasTexas Institute for Neurological DisordersNot yet recruitingMultiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple Sclerosis (SPMS)Japan
-
CelgeneCompletedHealthy VolunteersUnited States
-
Novartis PharmaceuticalsTerminatedActive DermatomyositisUnited States, Czechia, Japan
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisPoland, Hungary, Turkey, Spain, Germany, United States, Canada, Switzerland, Russian Federation, Norway, Italy, Finland
-
Novartis PharmaceuticalsTerminatedDermatomyositis | PolymyositisHungary, United States, Czechia, Sweden, United Kingdom
-
ActelionTerminatedChronic Graft Versus Host DiseaseUnited States
-
Jochen VehoffCompletedMultiple Sclerosis | Autonomic Nervous System DysfunctionSwitzerland
-
NovartisCompleted
-
Bristol-Myers SquibbRecruiting
-
CelgeneActive, not recruitingMultiple SclerosisUnited States, Canada, Puerto Rico
-
CelgeneCompletedHealthy VolunteersUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
NovartisCompletedRelapsing Multiple SclerosisGermany, Italy, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovakia, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
ActelionCompleted
-
Geert D'HaensBristol-Myers SquibbNot yet recruiting
-
Novartis PharmaceuticalsActive, not recruitingActive Secondary Progressive Multiple SclerosisItaly
-
ActelionCompletedPsoriasisAustria, Belgium, Bulgaria, Czechia, Denmark, France, Hungary, Italy, Lithuania, Romania, Russian Federation, Slovakia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisGermany, South Africa, Italy, United States, Austria, Belgium, Czechia, Egypt, Hungary, Malaysia, Turkey, Spain, Australia, Canada, France, Israel, Netherlands, Switzerland, Greece, Korea, Republic of, Romania, Russian Federation, United... and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis RRMSGermany, Switzerland
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
ActelionCompletedPharmacokineticsSwitzerland
-
NovartisCompletedMultiple SclerosisUnited States, Canada
-
NovartisMitsubishi Tanabe Pharma CorporationCompletedMultiple SclerosisJapan
-
NovartisCompleted
-
Novartis PharmaceuticalsRecruiting